AR 69 New Jersey General Assembly · 2026-2027 Regular Session

Urges NJ DOH to increase public awareness on effects of xylazine.

This non-binding resolution urges New Jersey's Department of Health to create public education materials about xylazine, a veterinary tranquilizer increasingly misused as a street drug. It highlights xylazine's dangers - including respiratory depression, skin ulcers, and its inability to be reversed by naloxone (unlike opioids) - and notes its frequent combination with fentanyl and other drugs in overdoses. The resolution specifically requests the health department provide accessible resources to inform residents about these risks. It does not create new laws but calls for public awareness efforts to address this emerging public health concern.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Health Committee
lower
2 primary · 3 co-sponsors

Sponsors